医学
二甲双胍
仿真
内科学
梅德林
肿瘤科
重症监护医学
家庭医学
胰岛素
政治学
法学
经济
经济增长
作者
Emilie Lambourg,Edouard L. Fu,Stuart J. McGurnaghan,Bryan R. Conway,Neeraj Dhaun,Christopher H. Grant,Ewan R. Pearson,Patrick B. Mark,John R. Petrie,Helen M. Colhoun,Samira Bell,Rory J. McCrimmon,Catherine Armstrong,Alistair Emslie‐Smith,Robert S. Lindsay,Sandra MacRury,John McKnight,Donald Pearson,Brian McKinstry
标识
DOI:10.1053/j.ajkd.2024.08.012
摘要
Current guidance recommends against the use of metformin in people with advanced kidney impairment despite a lack of supporting evidence. The aim of this observational study was to compare outcomes of patients with type 2 diabetes who continued versus stopped metformin after developing stage 4 chronic kidney disease (CKD) (eGFR <30 ml/min/1.73m
科研通智能强力驱动
Strongly Powered by AbleSci AI